Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels

Chest

Volumn 137, Issue 6, 2010, Pages 1369-1374

  Long, Ann C ^a   O'Neal Jr , Hollis R ^b   Peng, Suiwei ^b   Lane, Kirk B ^b   Light, Richard W ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARCINOMA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 77953298990     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2193     Document Type: Article

References (14)

1. Hall C. NT-ProBNP: the mechanism behind the marker. J Card Fail. 2005;11(5 suppl):S81-S83.
2. Hunt PJ, Espiner EA, Nicholls MG, et al. The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides. 1997;18(10):1475-1481.
3. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ. 2006;175(6):611-617.
4. Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Höffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J. 2006;28(1):144-150.
5. Porcel JM, Chorda J, Cao G, Esquerda A, Ruiz-González A, Vives M. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology. 2007;12(5): 654-659.
6. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M, Rivas MC. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med. 2004;116(6):417-420.
7. Tomcsányi J, Nagy E, Somlói M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail. 2004;6(6):753-756.
8. Liao H, Na MJ, Dikensoy O, Lane KB, Randal B, Light RW. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology. 2008;13(1):53-57.
9. Apple FS, Wu AH, Jaffe AS, et al; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines:Analytical issues for biomarkers of heart failure. Circulation. 2007;116(5):e95-e98.
10. Porcel JM, Martinez-Alonso M, Cao G, et al. Biomarkers of heart failure in pleural fluid. Chest. 2009 ;136(3):671-677.
11. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med. 2008;47(19):1669-1674.
12. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem. 2003;49(6 pt 1):976-979.
13. Azzazy HM, Christenson RH, Duh SH. Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems. Clin Chim Acta. 2007;384(1-2):176-178.
14. Apple FS, Panteghini M, Ravkilde J, et al; Committee on Standardization of Markers of Cardiac Damage of the IFCC. Quality specifications for B-type natriuretic peptide assays. Clin Chem. 2005;51(3):486-493.